Is Citizens, Inc. (Austin, Texas) overvalued or undervalued?

As of 8 May 2025, the valuation grade for Citizens, Inc. has moved from fair to very expensive, indicating a significant shift in its market perception. The company is currently deemed overvalued. Key ratios include a P/E ratio of 23, an EV to EBITDA of 129.70, and a Price to Book Value of 0.91. In comparison, peers such as eHealth, Inc. exhibit a much lower P/E of 5.34 and an EV to EBITDA of 0.25, while Clover Health Investments Corp. shows a negative P/E of -61.11, highlighting the disparity in valuation metrics.
The company's performance has also lagged behind broader market indices, with a year-to-date return of -14.21% compared to the S&P 500's 2.44%. Given these factors, Citizens, Inc. appears to be significantly overvalued in the current market environment.